Loading…
Reported covered position: U.S. Senator (1995-2013)
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
IRA Preservation Act of 2017
Client: COALITION FOR AMERICAN RETIREMENT LLC · Firm: COVINGTON & BURLING LLP
H.R. 4189, "IRA Preservation Act of 2017" (all provisions)
IRA Preservation Act of 2017
Client: COALITION FOR AMERICAN RETIREMENT LLC · Firm: COVINGTON & BURLING LLP
H.R. 4189, "IRA Preservation Act of 2017" (all provisions)
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
COALITION FOR AMERICAN RETIREMENT LLC via COVINGTON & BURLING LLP
2018 · third_quarter · Q3
H.R. 4189, "IRA Preservation Act of 2017" (all provisions)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GORDON SONDLAND via COVINGTON & BURLING LLP
2018 · second_quarter · 2T
Source: Senate LDA
| COALITION FOR AMERICAN RETIREMENT LLC |
| 4 |
| 2017–2018 |
| JW ALUMINUM | 4 | 2017–2018 |
| RAYTHEON COMPANY | 4 | 2015 |
| AMERICAN AUTOMOTIVE POLICY COUNCIL | 3 | 2015 |
| AMERICAN COUNCIL ON EDUCATION | 3 | 2017–2018 |
| GEORGETOWN UNIVERSITY | 3 | 2017–2018 |
| JUDICIAL CRISIS NETWORK | 3 | 2017 |
| MR. DONALD E. GRAHAM | 3 | 2017–2018 |
| FREEPORT-MCMORAN | 2 | 2018 |
| GORDON SONDLAND | 2 | 2018 |
| WALMART INC | 2 | 2016 |
| NORTHROP GRUMMAN | 1 | 2017 |
| SAP AMERICA INC. | 1 | 2017 |
IRA Preservation Act of 2017
Client: COALITION FOR AMERICAN RETIREMENT LLC · Firm: COVINGTON & BURLING LLP
H.R. 4189, "IRA Preservation Act of 2017" (all provisions)
Approving the discontinuation of the process for consideration and automatic implementation of the annual proposal of the Independent Medicare Advisory Board under section 1899A of the Social Security Act.
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Drug importation; Part D/non-interference; Biopharmaceutical innovation and patent policy issues; Bayh-Dole march-in rights policy issues; Independent Payment Advisory Board - Protecting Seniors' Access to Medicare Act of 2017 (H.R. 849); Approving the Discontinuation of the Process for Consideration and Automatic Implementation of the Annual Proposal of the Independent Medicare Advisory Board under Section 1899A of the Social Security Act(H.J. Res. 51); Protecting Medicare from Executive Action Act of 2017 (S. 251); A Joint Resolution Approving the Discontinuation of the Process for Consideration and Automatic Implementation of the Annual Proposal of the Independent Medicare Advisory Board under Section 1899A of the Social Security Act(S.J. Res. 16)
Recall Unsafe Drugs Act of 2017
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler Right to Try Act of 2017 (S.204); Biosimilar User Fee Act; Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (S. 3056); Lower Drug Costs through Competition Act (H.R. 749) and Senate counterpart (S. 297, Increasing Competition in Pharmaceuticals Act); Affordable and Safe Prescription Drug Importation Act (S. 469); RACE for Children Act (S. 456/H.R. 1231); Prescription Drug User Fee Act; Improving Access To Affordable Prescription Drugs Act (S.771/H.R. 1776); Preserve Access to Affordable Generics Act (S. 124); American Health Care Act, section Tax on prescription medications; Recall Unsafe Drugs Act of 2017 (H.R. 1108)
RACE for Children Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler Right to Try Act of 2017 (S.204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Food and Drug Administration Reauthorization Act (S. 934/H.R. 2430); Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017 (H.R. 2025); Medical Product Communications Act of 2017 (H.R. 1705); S. Amendment 178 to S. Con. Res. 3 (on importation of drugs from Canada); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Lower Drug Costs through Competition Act (H.R. 749) and Senate counterpart (S. 297, Increasing Competition in Pharmaceuticals Act); Affordable and Safe Prescription Drug Importation Act (S. 469/H.R. 1245); RACE for Children Act (S. 456/H.R. 1231); Safe and Affordable Drugs from Canada Act of 2017 (S. 92); Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018 (H.R.3268); Preserving Patient Access to Compounded Medications Act of 2017 (H.R. 2781)
RACE for Children Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler Right to Try Act of 2017 (S.204); Biosimilar User Fee Act; Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (S. 3056); Lower Drug Costs through Competition Act (H.R. 749) and Senate counterpart (S. 297, Increasing Competition in Pharmaceuticals Act); Affordable and Safe Prescription Drug Importation Act (S. 469); RACE for Children Act (S. 456/H.R. 1231); Prescription Drug User Fee Act; Improving Access To Affordable Prescription Drugs Act (S.771/H.R. 1776); Preserve Access to Affordable Generics Act (S. 124); American Health Care Act, section Tax on prescription medications; Recall Unsafe Drugs Act of 2017 (H.R. 1108)
Affordable and Safe Prescription Drug Importation Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler Right to Try Act of 2017 (S.204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Food and Drug Administration Reauthorization Act (S. 934/H.R. 2430); Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017 (H.R. 2025); Medical Product Communications Act of 2017 (H.R. 1705); S. Amendment 178 to S. Con. Res. 3 (on importation of drugs from Canada); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Lower Drug Costs through Competition Act (H.R. 749) and Senate counterpart (S. 297, Increasing Competition in Pharmaceuticals Act); Affordable and Safe Prescription Drug Importation Act (S. 469/H.R. 1245); RACE for Children Act (S. 456/H.R. 1231); Safe and Affordable Drugs from Canada Act of 2017 (S. 92); Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018 (H.R.3268); Preserving Patient Access to Compounded Medications Act of 2017 (H.R. 2781)
Keeping American Jobs Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler Right to Try Act of 2017 (S.204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Food and Drug Administration Reauthorization Act (S. 934/H.R. 2430); Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017 (H.R. 2025); Medical Product Communications Act of 2017 (H.R. 1705); S. Amendment 178 to S. Con. Res. 3 (on importation of drugs from Canada); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Lower Drug Costs through Competition Act (H.R. 749) and Senate counterpart (S. 297, Increasing Competition in Pharmaceuticals Act); Affordable and Safe Prescription Drug Importation Act (S. 469/H.R. 1245); RACE for Children Act (S. 456/H.R. 1231); Safe and Affordable Drugs from Canada Act of 2017 (S. 92); Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018 (H.R.3268); Preserving Patient Access to Compounded Medications Act of 2017 (H.R. 2781)
Improving Access To Affordable Prescription Drugs Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler Right to Try Act of 2017 (S.204); Biosimilar User Fee Act; Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (S. 3056); Lower Drug Costs through Competition Act (H.R. 749) and Senate counterpart (S. 297, Increasing Competition in Pharmaceuticals Act); Affordable and Safe Prescription Drug Importation Act (S. 469); RACE for Children Act (S. 456/H.R. 1231); Prescription Drug User Fee Act; Improving Access To Affordable Prescription Drugs Act (S.771/H.R. 1776); Preserve Access to Affordable Generics Act (S. 124); American Health Care Act, section Tax on prescription medications; Recall Unsafe Drugs Act of 2017 (H.R. 1108)
Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler Right to Try Act of 2017 (S.204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Food and Drug Administration Reauthorization Act (S. 934/H.R. 2430); Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017 (H.R. 2025); Medical Product Communications Act of 2017 (H.R. 1705); S. Amendment 178 to S. Con. Res. 3 (on importation of drugs from Canada); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Lower Drug Costs through Competition Act (H.R. 749) and Senate counterpart (S. 297, Increasing Competition in Pharmaceuticals Act); Affordable and Safe Prescription Drug Importation Act (S. 469/H.R. 1245); RACE for Children Act (S. 456/H.R. 1231); Safe and Affordable Drugs from Canada Act of 2017 (S. 92); Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018 (H.R.3268); Preserving Patient Access to Compounded Medications Act of 2017 (H.R. 2781)
FAST Generics Act of 2017
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler Right to Try Act of 2017 (S.204); Biosimilar User Fee Act; Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (S. 3056); Lower Drug Costs through Competition Act (H.R. 749) and Senate counterpart (S. 297, Increasing Competition in Pharmaceuticals Act); Affordable and Safe Prescription Drug Importation Act (S. 469); RACE for Children Act (S. 456/H.R. 1231); Prescription Drug User Fee Act; Improving Access To Affordable Prescription Drugs Act (S.771/H.R. 1776); Preserve Access to Affordable Generics Act (S. 124); American Health Care Act, section Tax on prescription medications; Recall Unsafe Drugs Act of 2017 (H.R. 1108)
FAST Generics Act of 2017
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler Right to Try Act of 2017 (S.204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Food and Drug Administration Reauthorization Act (S. 934/H.R. 2430); Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017 (H.R. 2025); Medical Product Communications Act of 2017 (H.R. 1705); S. Amendment 178 to S. Con. Res. 3 (on importation of drugs from Canada); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Lower Drug Costs through Competition Act (H.R. 749) and Senate counterpart (S. 297, Increasing Competition in Pharmaceuticals Act); Affordable and Safe Prescription Drug Importation Act (S. 469/H.R. 1245); RACE for Children Act (S. 456/H.R. 1231); Safe and Affordable Drugs from Canada Act of 2017 (S. 92); Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018 (H.R.3268); Preserving Patient Access to Compounded Medications Act of 2017 (H.R. 2781)
CREATES Act of 2017
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler Right to Try Act of 2017 (S.204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Food and Drug Administration Reauthorization Act (S. 934/H.R. 2430); Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017 (H.R. 2025); Medical Product Communications Act of 2017 (H.R. 1705); S. Amendment 178 to S. Con. Res. 3 (on importation of drugs from Canada); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Lower Drug Costs through Competition Act (H.R. 749) and Senate counterpart (S. 297, Increasing Competition in Pharmaceuticals Act); Affordable and Safe Prescription Drug Importation Act (S. 469/H.R. 1245); RACE for Children Act (S. 456/H.R. 1231); Safe and Affordable Drugs from Canada Act of 2017 (S. 92); Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018 (H.R.3268); Preserving Patient Access to Compounded Medications Act of 2017 (H.R. 2781)
FDA Reauthorization Act of 2017
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler Right to Try Act of 2017 (S.204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Food and Drug Administration Reauthorization Act (S. 934/H.R. 2430); Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017 (H.R. 2025); Medical Product Communications Act of 2017 (H.R. 1705); S. Amendment 178 to S. Con. Res. 3 (on importation of drugs from Canada); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Lower Drug Costs through Competition Act (H.R. 749) and Senate counterpart (S. 297, Increasing Competition in Pharmaceuticals Act); Affordable and Safe Prescription Drug Importation Act (S. 469/H.R. 1245); RACE for Children Act (S. 456/H.R. 1231); Safe and Affordable Drugs from Canada Act of 2017 (S. 92); Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018 (H.R.3268); Preserving Patient Access to Compounded Medications Act of 2017 (H.R. 2781)
Ensuring Veteran Enterprise Participation in Strategic Sourcing Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler Right to Try Act of 2017 (S.204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Food and Drug Administration Reauthorization Act (S. 934/H.R. 2430); Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017 (H.R. 2025); Medical Product Communications Act of 2017 (H.R. 1705); S. Amendment 178 to S. Con. Res. 3 (on importation of drugs from Canada); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Lower Drug Costs through Competition Act (H.R. 749) and Senate counterpart (S. 297, Increasing Competition in Pharmaceuticals Act); Affordable and Safe Prescription Drug Importation Act (S. 469/H.R. 1245); RACE for Children Act (S. 456/H.R. 1231); Safe and Affordable Drugs from Canada Act of 2017 (S. 92); Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018 (H.R.3268); Preserving Patient Access to Compounded Medications Act of 2017 (H.R. 2781)
SITSA Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler Right to Try Act of 2017 (S.204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Food and Drug Administration Reauthorization Act (S. 934/H.R. 2430); Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017 (H.R. 2025); Medical Product Communications Act of 2017 (H.R. 1705); S. Amendment 178 to S. Con. Res. 3 (on importation of drugs from Canada); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Lower Drug Costs through Competition Act (H.R. 749) and Senate counterpart (S. 297, Increasing Competition in Pharmaceuticals Act); Affordable and Safe Prescription Drug Importation Act (S. 469/H.R. 1245); RACE for Children Act (S. 456/H.R. 1231); Safe and Affordable Drugs from Canada Act of 2017 (S. 92); Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018 (H.R.3268); Preserving Patient Access to Compounded Medications Act of 2017 (H.R. 2781)
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler Right to Try Act of 2017 (S.204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Food and Drug Administration Reauthorization Act (S. 934/H.R. 2430); Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017 (H.R. 2025); Medical Product Communications Act of 2017 (H.R. 1705); S. Amendment 178 to S. Con. Res. 3 (on importation of drugs from Canada); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Lower Drug Costs through Competition Act (H.R. 749) and Senate counterpart (S. 297, Increasing Competition in Pharmaceuticals Act); Affordable and Safe Prescription Drug Importation Act (S. 469/H.R. 1245); RACE for Children Act (S. 456/H.R. 1231); Safe and Affordable Drugs from Canada Act of 2017 (S. 92); Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018 (H.R.3268); Preserving Patient Access to Compounded Medications Act of 2017 (H.R. 2781)
Lower Drug Costs through Competition Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler Right to Try Act of 2017 (S.204); Biosimilar User Fee Act; Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (S. 3056); Lower Drug Costs through Competition Act (H.R. 749) and Senate counterpart (S. 297, Increasing Competition in Pharmaceuticals Act); Affordable and Safe Prescription Drug Importation Act (S. 469); RACE for Children Act (S. 456/H.R. 1231); Prescription Drug User Fee Act; Improving Access To Affordable Prescription Drugs Act (S.771/H.R. 1776); Preserve Access to Affordable Generics Act (S. 124); American Health Care Act, section Tax on prescription medications; Recall Unsafe Drugs Act of 2017 (H.R. 1108)
Lower Drug Costs through Competition Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler Right to Try Act of 2017 (S.204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Food and Drug Administration Reauthorization Act (S. 934/H.R. 2430); Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017 (H.R. 2025); Medical Product Communications Act of 2017 (H.R. 1705); S. Amendment 178 to S. Con. Res. 3 (on importation of drugs from Canada); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Lower Drug Costs through Competition Act (H.R. 749) and Senate counterpart (S. 297, Increasing Competition in Pharmaceuticals Act); Affordable and Safe Prescription Drug Importation Act (S. 469/H.R. 1245); RACE for Children Act (S. 456/H.R. 1231); Safe and Affordable Drugs from Canada Act of 2017 (S. 92); Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018 (H.R.3268); Preserving Patient Access to Compounded Medications Act of 2017 (H.R. 2781)
Protecting Seniors Access to Medicare Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Drug importation; Part D/non-interference; Biopharmaceutical innovation and patent policy issues; Bayh-Dole march-in rights policy issues; Independent Payment Advisory Board - Protecting Seniors' Access to Medicare Act of 2017 (H.R. 849); Approving the Discontinuation of the Process for Consideration and Automatic Implementation of the Annual Proposal of the Independent Medicare Advisory Board under Section 1899A of the Social Security Act(H.J. Res. 51); Protecting Medicare from Executive Action Act of 2017 (S. 251); A Joint Resolution Approving the Discontinuation of the Process for Consideration and Automatic Implementation of the Annual Proposal of the Independent Medicare Advisory Board under Section 1899A of the Social Security Act(S.J. Res. 16)
Preserve Access to Affordable Generics Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler Right to Try Act of 2017 (S.204); Biosimilar User Fee Act; Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (S. 3056); Lower Drug Costs through Competition Act (H.R. 749) and Senate counterpart (S. 297, Increasing Competition in Pharmaceuticals Act); Affordable and Safe Prescription Drug Importation Act (S. 469); RACE for Children Act (S. 456/H.R. 1231); Prescription Drug User Fee Act; Improving Access To Affordable Prescription Drugs Act (S.771/H.R. 1776); Preserve Access to Affordable Generics Act (S. 124); American Health Care Act, section Tax on prescription medications; Recall Unsafe Drugs Act of 2017 (H.R. 1108)
SITSA Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler Right to Try Act of 2017 (S.204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Food and Drug Administration Reauthorization Act (S. 934/H.R. 2430); Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017 (H.R. 2025); Medical Product Communications Act of 2017 (H.R. 1705); S. Amendment 178 to S. Con. Res. 3 (on importation of drugs from Canada); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Lower Drug Costs through Competition Act (H.R. 749) and Senate counterpart (S. 297, Increasing Competition in Pharmaceuticals Act); Affordable and Safe Prescription Drug Importation Act (S. 469/H.R. 1245); RACE for Children Act (S. 456/H.R. 1231); Safe and Affordable Drugs from Canada Act of 2017 (S. 92); Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018 (H.R.3268); Preserving Patient Access to Compounded Medications Act of 2017 (H.R. 2781)
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler Right to Try Act of 2017 (S.204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Food and Drug Administration Reauthorization Act (S. 934/H.R. 2430); Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017 (H.R. 2025); Medical Product Communications Act of 2017 (H.R. 1705); S. Amendment 178 to S. Con. Res. 3 (on importation of drugs from Canada); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Lower Drug Costs through Competition Act (H.R. 749) and Senate counterpart (S. 297, Increasing Competition in Pharmaceuticals Act); Affordable and Safe Prescription Drug Importation Act (S. 469/H.R. 1245); RACE for Children Act (S. 456/H.R. 1231); Safe and Affordable Drugs from Canada Act of 2017 (S. 92); Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018 (H.R.3268); Preserving Patient Access to Compounded Medications Act of 2017 (H.R. 2781)
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler Right to Try Act of 2017 (S.204); Biosimilar User Fee Act; Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (S. 3056); Lower Drug Costs through Competition Act (H.R. 749) and Senate counterpart (S. 297, Increasing Competition in Pharmaceuticals Act); Affordable and Safe Prescription Drug Importation Act (S. 469); RACE for Children Act (S. 456/H.R. 1231); Prescription Drug User Fee Act; Improving Access To Affordable Prescription Drugs Act (S.771/H.R. 1776); Preserve Access to Affordable Generics Act (S. 124); American Health Care Act, section Tax on prescription medications; Recall Unsafe Drugs Act of 2017 (H.R. 1108)
Protecting Medicare from Executive Action Act of 2017
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Drug importation; Part D/non-interference; Biopharmaceutical innovation and patent policy issues; Bayh-Dole march-in rights policy issues; Independent Payment Advisory Board - Protecting Seniors' Access to Medicare Act of 2017 (H.R. 849); Approving the Discontinuation of the Process for Consideration and Automatic Implementation of the Annual Proposal of the Independent Medicare Advisory Board under Section 1899A of the Social Security Act(H.J. Res. 51); Protecting Medicare from Executive Action Act of 2017 (S. 251); A Joint Resolution Approving the Discontinuation of the Process for Consideration and Automatic Implementation of the Annual Proposal of the Independent Medicare Advisory Board under Section 1899A of the Social Security Act(S.J. Res. 16)
Increasing Competition in Pharmaceuticals Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler Right to Try Act of 2017 (S.204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Food and Drug Administration Reauthorization Act (S. 934/H.R. 2430); Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017 (H.R. 2025); Medical Product Communications Act of 2017 (H.R. 1705); S. Amendment 178 to S. Con. Res. 3 (on importation of drugs from Canada); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Lower Drug Costs through Competition Act (H.R. 749) and Senate counterpart (S. 297, Increasing Competition in Pharmaceuticals Act); Affordable and Safe Prescription Drug Importation Act (S. 469/H.R. 1245); RACE for Children Act (S. 456/H.R. 1231); Safe and Affordable Drugs from Canada Act of 2017 (S. 92); Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018 (H.R.3268); Preserving Patient Access to Compounded Medications Act of 2017 (H.R. 2781)
Increasing Competition in Pharmaceuticals Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler Right to Try Act of 2017 (S.204); Biosimilar User Fee Act; Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (S. 3056); Lower Drug Costs through Competition Act (H.R. 749) and Senate counterpart (S. 297, Increasing Competition in Pharmaceuticals Act); Affordable and Safe Prescription Drug Importation Act (S. 469); RACE for Children Act (S. 456/H.R. 1231); Prescription Drug User Fee Act; Improving Access To Affordable Prescription Drugs Act (S.771/H.R. 1776); Preserve Access to Affordable Generics Act (S. 124); American Health Care Act, section Tax on prescription medications; Recall Unsafe Drugs Act of 2017 (H.R. 1108)
North American Energy Infrastructure Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler Right to Try Act of 2017 (S.204); Biosimilar User Fee Act; Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (S. 3056); Lower Drug Costs through Competition Act (H.R. 749) and Senate counterpart (S. 297, Increasing Competition in Pharmaceuticals Act); Affordable and Safe Prescription Drug Importation Act (S. 469); RACE for Children Act (S. 456/H.R. 1231); Prescription Drug User Fee Act; Improving Access To Affordable Prescription Drugs Act (S.771/H.R. 1776); Preserve Access to Affordable Generics Act (S. 124); American Health Care Act, section Tax on prescription medications; Recall Unsafe Drugs Act of 2017 (H.R. 1108)
RACE for Children Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler Right to Try Act of 2017 (S.204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Food and Drug Administration Reauthorization Act (S. 934/H.R. 2430); Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017 (H.R. 2025); Medical Product Communications Act of 2017 (H.R. 1705); S. Amendment 178 to S. Con. Res. 3 (on importation of drugs from Canada); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Lower Drug Costs through Competition Act (H.R. 749) and Senate counterpart (S. 297, Increasing Competition in Pharmaceuticals Act); Affordable and Safe Prescription Drug Importation Act (S. 469/H.R. 1245); RACE for Children Act (S. 456/H.R. 1231); Safe and Affordable Drugs from Canada Act of 2017 (S. 92); Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018 (H.R.3268); Preserving Patient Access to Compounded Medications Act of 2017 (H.R. 2781)
RACE for Children Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler Right to Try Act of 2017 (S.204); Biosimilar User Fee Act; Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (S. 3056); Lower Drug Costs through Competition Act (H.R. 749) and Senate counterpart (S. 297, Increasing Competition in Pharmaceuticals Act); Affordable and Safe Prescription Drug Importation Act (S. 469); RACE for Children Act (S. 456/H.R. 1231); Prescription Drug User Fee Act; Improving Access To Affordable Prescription Drugs Act (S.771/H.R. 1776); Preserve Access to Affordable Generics Act (S. 124); American Health Care Act, section Tax on prescription medications; Recall Unsafe Drugs Act of 2017 (H.R. 1108)
Affordable and Safe Prescription Drug Importation Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler Right to Try Act of 2017 (S.204); Biosimilar User Fee Act; Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (S. 3056); Lower Drug Costs through Competition Act (H.R. 749) and Senate counterpart (S. 297, Increasing Competition in Pharmaceuticals Act); Affordable and Safe Prescription Drug Importation Act (S. 469); RACE for Children Act (S. 456/H.R. 1231); Prescription Drug User Fee Act; Improving Access To Affordable Prescription Drugs Act (S.771/H.R. 1776); Preserve Access to Affordable Generics Act (S. 124); American Health Care Act, section Tax on prescription medications; Recall Unsafe Drugs Act of 2017 (H.R. 1108)
Affordable and Safe Prescription Drug Importation Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler Right to Try Act of 2017 (S.204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Food and Drug Administration Reauthorization Act (S. 934/H.R. 2430); Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017 (H.R. 2025); Medical Product Communications Act of 2017 (H.R. 1705); S. Amendment 178 to S. Con. Res. 3 (on importation of drugs from Canada); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Lower Drug Costs through Competition Act (H.R. 749) and Senate counterpart (S. 297, Increasing Competition in Pharmaceuticals Act); Affordable and Safe Prescription Drug Importation Act (S. 469/H.R. 1245); RACE for Children Act (S. 456/H.R. 1231); Safe and Affordable Drugs from Canada Act of 2017 (S. 92); Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018 (H.R.3268); Preserving Patient Access to Compounded Medications Act of 2017 (H.R. 2781)
Improving Access To Affordable Prescription Drugs Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler Right to Try Act of 2017 (S.204); Biosimilar User Fee Act; Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (S. 3056); Lower Drug Costs through Competition Act (H.R. 749) and Senate counterpart (S. 297, Increasing Competition in Pharmaceuticals Act); Affordable and Safe Prescription Drug Importation Act (S. 469); RACE for Children Act (S. 456/H.R. 1231); Prescription Drug User Fee Act; Improving Access To Affordable Prescription Drugs Act (S.771/H.R. 1776); Preserve Access to Affordable Generics Act (S. 124); American Health Care Act, section Tax on prescription medications; Recall Unsafe Drugs Act of 2017 (H.R. 1108)
Safe and Affordable Drugs from Canada Act of 2017
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler Right to Try Act of 2017 (S.204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Food and Drug Administration Reauthorization Act (S. 934/H.R. 2430); Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017 (H.R. 2025); Medical Product Communications Act of 2017 (H.R. 1705); S. Amendment 178 to S. Con. Res. 3 (on importation of drugs from Canada); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Lower Drug Costs through Competition Act (H.R. 749) and Senate counterpart (S. 297, Increasing Competition in Pharmaceuticals Act); Affordable and Safe Prescription Drug Importation Act (S. 469/H.R. 1245); RACE for Children Act (S. 456/H.R. 1231); Safe and Affordable Drugs from Canada Act of 2017 (S. 92); Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018 (H.R.3268); Preserving Patient Access to Compounded Medications Act of 2017 (H.R. 2781)
FDA Reauthorization Act of 2017
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler Right to Try Act of 2017 (S.204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Food and Drug Administration Reauthorization Act (S. 934/H.R. 2430); Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017 (H.R. 2025); Medical Product Communications Act of 2017 (H.R. 1705); S. Amendment 178 to S. Con. Res. 3 (on importation of drugs from Canada); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Lower Drug Costs through Competition Act (H.R. 749) and Senate counterpart (S. 297, Increasing Competition in Pharmaceuticals Act); Affordable and Safe Prescription Drug Importation Act (S. 469/H.R. 1245); RACE for Children Act (S. 456/H.R. 1231); Safe and Affordable Drugs from Canada Act of 2017 (S. 92); Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018 (H.R.3268); Preserving Patient Access to Compounded Medications Act of 2017 (H.R. 2781)
Creating and Restoring Equal Access to Equivalent Samples Act of 2018
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler Right to Try Act of 2017 (S.204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Food and Drug Administration Reauthorization Act (S. 934/H.R. 2430); Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017 (H.R. 2025); Medical Product Communications Act of 2017 (H.R. 1705); S. Amendment 178 to S. Con. Res. 3 (on importation of drugs from Canada); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Lower Drug Costs through Competition Act (H.R. 749) and Senate counterpart (S. 297, Increasing Competition in Pharmaceuticals Act); Affordable and Safe Prescription Drug Importation Act (S. 469/H.R. 1245); RACE for Children Act (S. 456/H.R. 1231); Safe and Affordable Drugs from Canada Act of 2017 (S. 92); Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018 (H.R.3268); Preserving Patient Access to Compounded Medications Act of 2017 (H.R. 2781)
A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026.
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler Right to Try Act of 2017 (S.204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Food and Drug Administration Reauthorization Act (S. 934/H.R. 2430); Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017 (H.R. 2025); Medical Product Communications Act of 2017 (H.R. 1705); S. Amendment 178 to S. Con. Res. 3 (on importation of drugs from Canada); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Lower Drug Costs through Competition Act (H.R. 749) and Senate counterpart (S. 297, Increasing Competition in Pharmaceuticals Act); Affordable and Safe Prescription Drug Importation Act (S. 469/H.R. 1245); RACE for Children Act (S. 456/H.R. 1231); Safe and Affordable Drugs from Canada Act of 2017 (S. 92); Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018 (H.R.3268); Preserving Patient Access to Compounded Medications Act of 2017 (H.R. 2781)
A joint resolution approving the discontinuation of the process for consideration and automatic implementation of the annual proposal of the Independent Medicare Advisory Board under section 1899A of the Social Security Act.
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Drug importation; Part D/non-interference; Biopharmaceutical innovation and patent policy issues; Bayh-Dole march-in rights policy issues; Independent Payment Advisory Board - Protecting Seniors' Access to Medicare Act of 2017 (H.R. 849); Approving the Discontinuation of the Process for Consideration and Automatic Implementation of the Annual Proposal of the Independent Medicare Advisory Board under Section 1899A of the Social Security Act(H.J. Res. 51); Protecting Medicare from Executive Action Act of 2017 (S. 251); A Joint Resolution Approving the Discontinuation of the Process for Consideration and Automatic Implementation of the Annual Proposal of the Independent Medicare Advisory Board under Section 1899A of the Social Security Act(S.J. Res. 16)
Opposing the CREATES Act, S. 3056
Opposing the CREATES Act, S. 3056
Opposing the CREATES Act, S. 3056
Opposing the CREATES Act, S. 3056
Assisting Mr. Sondland in preparation for confirmation to be the next U.S. Ambassador to the European Union.
Filing targets: SENATE, State, Dept of (DOS)
COALITION FOR AMERICAN RETIREMENT LLC via COVINGTON & BURLING LLP
2018 · second_quarter · Q2
H.R. 4189, "IRA Preservation Act of 2017" (all provisions)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GORDON SONDLAND via COVINGTON & BURLING LLP
2018 · second_quarter · RR
Assisting Mr. Sondland in preparation for confirmation to be the next US Ambassador to the European Union.
FREEPORT-MCMORAN via COVINGTON & BURLING LLP
2018 · first_quarter · Q1
Advocating that copper be included on the draft list of critical minerals.
Filing targets: Council on Environmental Quality (CEQ)
QUALCOMM INCORPORATED via COVINGTON & BURLING LLP
2018 · first_quarter · Q1
Patent reform generally; Intellectual property/antitrust issues; International/antitrust issues; Diversity issues in patenting.
Filing targets: Defense, Dept of (DOD), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office
FREEPORT-MCMORAN via COVINGTON & BURLING LLP
2018 · first_quarter · RR
Advocating that copper be included on the draft list of critical minerals.
MR. DONALD E. GRAHAM via COVINGTON & BURLING LLP
2018 · first_quarter · 1T
Extension of Deferred Action for Childhood Arrivals program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GEORGETOWN UNIVERSITY via COVINGTON & BURLING LLP
2018 · first_quarter · 1T
Extension of Deferred Action for Childhood Arrivals program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN COUNCIL ON EDUCATION via COVINGTON & BURLING LLP
2018 · first_quarter · 1T
Extension of Deferred Action for Childhood Arrivals program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR AMERICAN RETIREMENT LLC via COVINGTON & BURLING LLP
2018 · first_quarter · Q1
H.R. 4189, "IRA Preservation Act of 2017" (all provisions)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
JW ALUMINUM via COVINGTON & BURLING LLP
2018 · first_quarter · Q1
Application of Internal Revenue Code to "related persons"
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN COUNCIL ON EDUCATION via COVINGTON & BURLING LLP
2017 · fourth_quarter · Q4
Extension of Deferred Action for Childhood Arrivals program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MR. DONALD E. GRAHAM via COVINGTON & BURLING LLP
2017 · fourth_quarter · Q4
Extension of Deferred Action for Childhood Arrivals program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GEORGETOWN UNIVERSITY via COVINGTON & BURLING LLP
2017 · fourth_quarter · Q4
Extension of Deferred Action for Childhood Arrivals program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SAP AMERICA, INC. via COVINGTON & BURLING LLP
2017 · fourth_quarter · Q4
Tax reform legislation.
Filing targets: HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE
NORTHROP GRUMMAN via COVINGTON & BURLING LLP
2017 · fourth_quarter · Q4
Tax Reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
QUALCOMM INCORPORATED via COVINGTON & BURLING LLP
2017 · fourth_quarter · Q4
Patent reform generally; Intellectual property/antitrust issues; International/antitrust issues; Diversity issues in patenting.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
COALITION FOR AMERICAN RETIREMENT LLC via COVINGTON & BURLING LLP
2017 · fourth_quarter · Q4
Individual Retirement Account Preservation Act of 2017 (no bill number; all provisions); issues related to individual retirement account tax reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
JW ALUMINUM via COVINGTON & BURLING LLP
2017 · fourth_quarter · Q4
Application of Internal Revenue Code to "related persons"
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN COUNCIL ON EDUCATION via COVINGTON & BURLING LLP
2017 · fourth_quarter · RA
Extension of Deferred Action for Childhood Arrivals program.
MERCK & CO, INC via COVINGTON & BURLING LLP
2017 · third_quarter · Q3
International tax reform policy.
Filing targets: HOUSE OF REPRESENTATIVES
QUALCOMM INCORPORATED via COVINGTON & BURLING LLP
2017 · third_quarter · Q3
Patent reform generally; Intellectual property/antitrust issues; International/antitrust issues; Diversity issues in patenting.
Filing targets: HOUSE OF REPRESENTATIVES, Office of the Vice President of the United States, Patent & Trademark Office (PTO), SENATE, U.S. Trade Representative (USTR), White House Office
PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC via COVINGTON & BURLING LLP
2017 · third_quarter · Q3
Drug importation; Part D/non-interference; Biopharmaceutical innovation and patent policy issues; Bayh-Dole march-in rights policy issues; Independent Payment Advisory Board - Protecting Seniors' Access to Medicare Act of 2017 (H.R. 849); Approving the Discontinuation of the Process for Consideration and Automatic Implementation of the Annual Proposal of the Independent Medicare Advisory Board under Section 1899A of the Social Security Act(H.J. Res. 51); Protecting Medicare from Executive Action Act of 2017 (S. 251); A Joint Resolution Approving the Discontinuation of the Process for Consideration and Automatic Implementation of the Annual Proposal of the Independent Medicare Advisory Board under Section 1899A of the Social Security Act(S.J. Res. 16)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GEORGETOWN UNIVERSITY via COVINGTON & BURLING LLP
2017 · third_quarter · Q3
Extension of Deferred Action for Childhood Arrivals program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MR. DONALD E. GRAHAM via COVINGTON & BURLING LLP
2017 · third_quarter · Q3
Extension of Deferred Action for Childhood Arrivals program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MERCK & CO, INC via COVINGTON & BURLING LLP
2017 · third_quarter · RA
International tax reform policy.
JW ALUMINUM via COVINGTON & BURLING LLP
2017 · third_quarter · Q3
Application of Internal Revenue Code to "related persons"
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC via COVINGTON & BURLING LLP
2017 · second_quarter · Q2
Trickett Wendler Right to Try Act of 2017 (S.204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Food and Drug Administration Reauthorization Act (S. 934/H.R. 2430); Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017 (H.R. 2025); Medical Product Communications Act of 2017 (H.R. 1705); S. Amendment 178 to S. Con. Res. 3 (on importation of drugs from Canada); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Lower Drug Costs through Competition Act (H.R. 749) and Senate counterpart (S. 297, Increasing Competition in Pharmaceuticals Act); Affordable and Safe Prescription Drug Importation Act (S. 469/H.R. 1245); RACE for Children Act (S. 456/H.R. 1231); Safe and Affordable Drugs from Canada Act of 2017 (S. 92); Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018 (H.R.3268); Preserving Patient Access to Compounded Medications Act of 2017 (H.R. 2781)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
JW ALUMINUM via COVINGTON & BURLING LLP
2017 · second_quarter · Q2
Application of Internal Revenue Code to "related persons"
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
QUALCOMM INCORPORATED via COVINGTON & BURLING LLP
2017 · first_quarter · 1A
Patent reform generally Intellectual property/antitrust issues International/antitrust issues
Filing targets: Commerce, Dept of (DOC), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office
QUALCOMM INCORPORATED via COVINGTON & BURLING LLP
2017 · second_quarter · Q2
Patent reform generally Intellectual property/antitrust issues International/antitrust issues
Filing targets: Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Office of the Vice President of the United States, Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), White House Office
JUDICIAL CRISIS NETWORK via COVINGTON & BURLING LLP
2017 · second_quarter · 2T
Support the confirmation of Neil Gorsuch to the U.S. Supreme Court, prepare for possible additional Supreme Court vacancy.
Filing targets: SENATE, White House Office
QUALCOMM INCORPORATED via COVINGTON & BURLING LLP
2017 · first_quarter · Q1
Patent reform generally Intellectual property/antitrust issues International/antitrust issues
Filing targets: Commerce, Dept of (DOC), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office
PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC via COVINGTON & BURLING LLP
2017 · first_quarter · Q1
Trickett Wendler Right to Try Act of 2017 (S.204); Biosimilar User Fee Act; Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (S. 3056); Lower Drug Costs through Competition Act (H.R. 749) and Senate counterpart (S. 297, Increasing Competition in Pharmaceuticals Act); Affordable and Safe Prescription Drug Importation Act (S. 469); RACE for Children Act (S. 456/H.R. 1231); Prescription Drug User Fee Act; Improving Access To Affordable Prescription Drugs Act (S.771/H.R. 1776); Preserve Access to Affordable Generics Act (S. 124); American Health Care Act, section Tax on prescription medications; Recall Unsafe Drugs Act of 2017 (H.R. 1108)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
JUDICIAL CRISIS NETWORK via COVINGTON & BURLING LLP
2017 · first_quarter · Q1
Support the confirmation of Neil Gorsuch to the U.S. Supreme Court
Filing targets: SENATE, White House Office
JUDICIAL CRISIS NETWORK via COVINGTON & BURLING LLP
2017 · first_quarter · RR
Support confirmation of Neil Gorsuch to Supreme Court
PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC via COVINGTON & BURLING LLP
2016 · fourth_quarter · Q4
CMMI Part B demonstration; 21st Century Cures; Patent Litigation Reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H&R BLOCK, INC via COVINGTON & BURLING LLP
2016 · fourth_quarter · 4T
Support the creation of minimum standards for paid tax preparers.
Filing targets: SENATE
CELGENE CORPORATION via COVINGTON & BURLING LLP
2016 · fourth_quarter · Q4
Opposing the CREATES Act, S. 3056
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H&R BLOCK, INC via COVINGTON & BURLING LLP
2016 · third_quarter · Q3
Support the creation of minimum standards for paid tax preparers.
Filing targets: SENATE
PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC via COVINGTON & BURLING LLP
2016 · third_quarter · Q3
Legislative Drug Pricing Issues; CMMI Part B demonstration; Integrity of the Part D program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WALMART INC via COVINGTON & BURLING LLP
2016 · third_quarter · Q3
DoD TRICARE Program; FY 2017 National Defense Authorization Act
DoD TRICARE Program; FY 2017 National Defense Authorization Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CELGENE CORPORATION via COVINGTON & BURLING LLP
2016 · third_quarter · Q3
Opposing the CREATES Act, S. 3056
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CELGENE CORPORATION via COVINGTON & BURLING LLP
2016 · second_quarter · Q2
Opposing the CREATES Act, S. 3056
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC via COVINGTON & BURLING LLP
2016 · second_quarter · Q2
Legislative Drug Pricing Issues; CMMI Part B demonstration; Integrity of the Part D program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WALMART INC via COVINGTON & BURLING LLP
2016 · second_quarter · Q2
DoD TRICARE Program; FY 2017 National Defense Authorization Act
DoD TRICARE Program; FY 2017 National Defense Authorization Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ANHEUSER-BUSCH COMPANIES, INC via COVINGTON & BURLING LLP
2016 · second_quarter · Q2
Proposed merger between Anheuser-Busch InBev and SABMiller
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MERCK & CO, INC via COVINGTON & BURLING LLP
2016 · second_quarter · Q2
International tax reform policy and the treatment of IP
Filing targets: SENATE
H&R BLOCK, INC via COVINGTON & BURLING LLP
2016 · second_quarter · Q2
Support the creation of minimum standards for paid tax preparers
Filing targets: SENATE
CELGENE CORPORATION via COVINGTON & BURLING LLP
2016 · second_quarter · RR
Opposing the CREATES Act, S. 3056
PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC via COVINGTON & BURLING LLP
2016 · first_quarter · Q1
Legislative Drug Patent and Pricing Issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ANHEUSER-BUSCH COMPANIES, INC via COVINGTON & BURLING LLP
2016 · first_quarter · Q1
Proposed merger between Anheuser-Busch InBev and SABMiller
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MERCK & CO, INC via COVINGTON & BURLING LLP
2016 · first_quarter · Q1
International tax reform policy and the treatment of IP
Filing targets: SENATE
H&R BLOCK, INC via COVINGTON & BURLING LLP
2016 · first_quarter · Q1
Support the creation of minimum standards for paid tax preparers
Filing targets: SENATE
H&R BLOCK, INC via COVINGTON & BURLING LLP
2016 · first_quarter · RR
Support the creation of minimum standards for paid tax preparers
RAYTHEON COMPANY via COVINGTON & BURLING LLP
2015 · third_quarter · 3A
Issues associated with sales of Patriot missile systems to Poland and Germany.
Filing targets: HOUSE OF REPRESENTATIVES
PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC via COVINGTON & BURLING LLP
2015 · fourth_quarter · Q4
Drug Legislation Issues.
ANHEUSER-BUSCH COMPANIES, INC via COVINGTON & BURLING LLP
2015 · fourth_quarter · Q4
Proposed merger between Anheuser-Busch InBev and SABMiller
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MERCK & CO, INC via COVINGTON & BURLING LLP
2015 · fourth_quarter · Q4
International tax reform policy and the treatment of IP
Filing targets: SENATE
ANHEUSER-BUSCH COMPANIES, INC via COVINGTON & BURLING LLP
2015 · fourth_quarter · RR
Proposed merger between Anheuser-Busch InBev and SABMiller
Proposed merger between Anheuser-Busch InBev and SABMiller
MERCK & CO, INC via COVINGTON & BURLING LLP
2015 · third_quarter · Q3
International tax reform policy and the treatment of IP
Filing targets: SENATE
RAYTHEON COMPANY via COVINGTON & BURLING LLP
2015 · third_quarter · Q3
Issues associated with sales of Patriot missile systems to Poland and Germany.
Filing targets: HOUSE OF REPRESENTATIVES
PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC via COVINGTON & BURLING LLP
2015 · third_quarter · Q3
Drug Legislation Issues. Trade Secret Issues.
MERCK & CO, INC via COVINGTON & BURLING LLP
2015 · second_quarter · Q2
International tax reform policy and the treatment of IP
Filing targets: SENATE
PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC via COVINGTON & BURLING LLP
2015 · second_quarter · Q2
Patent Reform Legislation, Senate Bill 1137
Filing targets: Patent & Trademark Office (PTO), SENATE
AMERICAN AUTOMOTIVE POLICY COUNCIL via COVINGTON & BURLING LLP
2015 · second_quarter · 2T
Add currency provisions to Trade Promotion Authority and Trans-Pacific Partnership
Filing targets: SENATE
MERCK & CO, INC via COVINGTON & BURLING LLP
2015 · second_quarter · RA
Tax reform policy
RAYTHEON COMPANY via COVINGTON & BURLING LLP
2015 · first_quarter · Q1
Issues associated with U.S. government's response to Poland's request for proposal for missile system.
Filing targets: Defense, Dept of (DOD), Natl Security Council (NSC), SENATE, State, Dept of (DOS)
AMERICAN AUTOMOTIVE POLICY COUNCIL via COVINGTON & BURLING LLP
2015 · first_quarter · Q1
Add currency provisions to Trade Promotion Authority and Trans-Pacific Partnership
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RAYTHEON COMPANY via COVINGTON & BURLING LLP
2015 · first_quarter · RR
Issues associated with U.S. governments response to Polands request for proposal for missile system.
AMERICAN AUTOMOTIVE POLICY COUNCIL via COVINGTON & BURLING LLP
2015 · first_quarter · RR
Add currency provisions to Trade Promotion Authority and Trans-Pacific Partnership